James Sapirstein insider trades

Open-market stock purchases and sales by James Sapirstein, Director at Inmune Bio, Inc, from SEC Form 4 filings since Nov 8, 2012.

Recent trades

DateStockTradeValue
Sep 15, 2026INMB Inmune Bio, IncBought (not open market)—
Jun 3, 2026COCP Cocrystal Pharma, IncBought (not open market)—

Companies traded

  • INMB Inmune Bio, Inc: other filings, last Sep 15, 2026
  • COCP Cocrystal Pharma, Inc: other filings, last Jun 3, 2026
  • ZVSA ZyVersa Therapeutics, Inc: other filings, last Jul 11, 2025
  • ONCO Onconetix, Inc: other filings, last Sep 26, 2024
  • ENTO Entero Therapeutics, Inc: 1 sale, last Jul 2, 2024
  • RENB Renovaro Inc: other filings, last Jun 25, 2024
  • FWBI First Wave BioPharma, Inc: 6 sales, last Apr 1, 2024
  • BWV Blue Water Biotech, Inc: other filings, last May 31, 2023
  • ENOB Enochian Biosciences Inc: other filings, last Mar 6, 2023
  • AZRX AzurRx BioPharma, Inc: other filings, last Jun 30, 2021
  • MRZM Marizyme Inc: other filings, last Mar 5, 2021
  • CTRV ContraVir Pharmaceuticals, Inc: 3 buys, last Jan 3, 2018

Get free alerts when James Sapirstein files a new trade →